“Post tuberculosis”: the urgent need for inclusion of lung
health outcomes in tuberculosis treatment trials

Anthony Byrne; Brian Allwood; Ingrid Schoeman; James Johnston; Gautam Kalyatanda; Goodman Makanda; Kevin Mortimer; Carole Mitnick; Becky Nightingale; Obianuju Ozoh; Andrea Rachow; Marieke Van Der Zalm

doi:10.1183/13993003.00950-2023

“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials

Anthony Byrne, Brian Allwood, Ingrid Schoeman, James Johnston, Gautam Kalyatanda, Goodman Makanda, Kevin Mortimer, Carole Mitnick, Becky Nightingale, Obianuju Ozoh, Andrea Rachow, Marieke Van Der Zalm

Research output: Contribution to journal › Letter › peer-review

9 Citations (Scopus)

Abstract

New TB treatment regimens are a welcome advancement. However, for the millions of TB survivors with impaired lung function and quality of life, more holistic outcome measures and the inclusion of lung function is essential in future TB treatment trials.

Original language	English
Article number	2300950
Pages (from-to)	2300950
Journal	European Respiratory Journal
Volume	62
Issue number	3
Early online date	9 Sept 2023
DOIs	https://doi.org/10.1183/13993003.00950-2023
Publication status	E-pub ahead of print - 9 Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1183/13993003.00950-2023Licence: CC BY-NC

2300950Final published version, 407 KBLicence: CC BY

Cite this

Byrne, A., Allwood, B., Schoeman, I., Johnston, J., Kalyatanda, G., Makanda, G., Mortimer, K., Mitnick, C., Nightingale, B., Ozoh, O., Rachow, A., & Van Der Zalm, M. (2023). “Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials. European Respiratory Journal, 62(3), 2300950. Article 2300950. Advance online publication. https://doi.org/10.1183/13993003.00950-2023

@article{91b8a6bc453342edafccbdda284192ae,

title = "“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials",

abstract = "New TB treatment regimens are a welcome advancement. However, for the millions of TB survivors with impaired lung function and quality of life, more holistic outcome measures and the inclusion of lung function is essential in future TB treatment trials.",

author = "Anthony Byrne and Brian Allwood and Ingrid Schoeman and James Johnston and Gautam Kalyatanda and Goodman Makanda and Kevin Mortimer and Carole Mitnick and Becky Nightingale and Obianuju Ozoh and Andrea Rachow and \{Van Der Zalm\}, Marieke",

year = "2023",

month = sep,

day = "9",

doi = "10.1183/13993003.00950-2023",

language = "English",

volume = "62",

pages = "2300950",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

Byrne, A, Allwood, B, Schoeman, I, Johnston, J, Kalyatanda, G, Makanda, G, Mortimer, K, Mitnick, C, Nightingale, B, Ozoh, O, Rachow, A & Van Der Zalm, M 2023, '“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials', European Respiratory Journal, vol. 62, no. 3, 2300950, pp. 2300950. https://doi.org/10.1183/13993003.00950-2023

TY - JOUR

T1 - “Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials

AU - Byrne, Anthony

AU - Allwood, Brian

AU - Schoeman, Ingrid

AU - Johnston, James

AU - Kalyatanda, Gautam

AU - Makanda, Goodman

AU - Mortimer, Kevin

AU - Mitnick, Carole

AU - Nightingale, Becky

AU - Ozoh, Obianuju

AU - Rachow, Andrea

AU - Van Der Zalm, Marieke

PY - 2023/9/9

Y1 - 2023/9/9

N2 - New TB treatment regimens are a welcome advancement. However, for the millions of TB survivors with impaired lung function and quality of life, more holistic outcome measures and the inclusion of lung function is essential in future TB treatment trials.

AB - New TB treatment regimens are a welcome advancement. However, for the millions of TB survivors with impaired lung function and quality of life, more holistic outcome measures and the inclusion of lung function is essential in future TB treatment trials.

U2 - 10.1183/13993003.00950-2023

DO - 10.1183/13993003.00950-2023

M3 - Letter

SN - 0903-1936

VL - 62

SP - 2300950

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 3

M1 - 2300950

ER -

“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this